Evidence map›Paper›PMID 35837360›Full record

ArticleGlobal heart2022

Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF).

Phyllis Sin, Muhammad Siddiqui, Rashell Wozniak, Idris Bare, Jessica Minion, Stephen Sanche, Jacob Udell, Andrea Lavoie, Payam Dehghani

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Global heart, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Phyllis SinUniversity of Manitoba, The Max Rady College of Medicine, Winnipeg, MB, CA.ORCID 0000-0002-0483-7815
Muhammad SiddiquiSaskatchewan Health Authority, Research Department, Regina, SK, CA.
Rashell WozniakUniversity of Alberta, Edmonton, AB, CA.ORCID 0000-0001-8063-2523
Idris BareUniversity of Saskatchewan, College of Medicine, Saskatoon, SK, CA.
Jessica MinionUniversity of Saskatchewan, College of Medicine, Regina, SK, CA.ORCID 0000-0002-8863-5697
Stephen SancheUniversity of Saskatchewan, College of Medicine, Saskatoon, SK, CA.ORCID 0000-0003-3643-5973
Jacob UdellUniversity of Toronto, Faculty of Medicine, Toronto, ON, CA.ORCID 0000-0001-7402-9584
Andrea LavoieUniversity of Saskatchewan, College of Medicine, Regina, SK, CA.ORCID 0000-0002-2141-9359
Payam DehghaniUniversity of Saskatchewan, College of Medicine, Regina, SK, CA.ORCID 0000-0001-7858-7989
University of Regina · CAUniversity of Saskatchewan · CASaskatchewan Health Authority · CAUniversity of Alberta · CAUniversity of Manitoba · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Influenza has been shown to exacerbate heart failure (HF). Importantly, no study to date has examined the relationship between HF hospitalizations (HFH) with laboratory confirmed influenza infections. This study evaluated the association between laboratory confirmed influenza infection and HFH in the two largest hospitals in Saskatchewan, Canada. Methods: We used a retrospective self-controlled case series design to evaluate the association between laboratory-confirmed influenza infection and HFH. We compared the incidence ratio for HFH during the influenza risk interval with the control interval. We defined the influenza risk interval as the seven days after a laboratory confirmed influenza result and the control interval as one year before and after the risk interval. Results: We identified 114 HFH that occurred within one year before and after a positive test result for influenza between April 1, 2010, and April 30, 2018. Of these, 28 (28 admissions per week) occurred during the risk interval and 86 (0.853 admissions per week) occurred during the control interval. The incidence ratio of a HFH during the risk interval as compared with the control interval was 33.53 (95% confidence interval [CI], 21.89 to 51.36). A decline in incidence was observed after day seven; between days 8 to 14 and 14 to 28 incidence ratios was 0.91 (95% CI, 0.13 to 6.52) and 0.91 (95% CI, 0.22 to 3.68) respectively. Conclusion: We have observed a significant association between acute influenza infection and HFH. However, further research with a larger sample size and involving a multicenter setting is warranted. Highlights: Influenza may contribute and exacerbate heart failure events especially during annual influenza season.Early identification of influenza among patients with heart failure, could lead to earlier treatment with antiviral medication, reduce unnecessary antibiotic use, and tail off the morbidity and mortality.In this study, despite our efficient study design, our sample size was limited to only the two largest hospitals in the province, possibly excluding a significant population in remote areas.

Indexed as

Heart FailureInfluenza, HumanHospitalizationHumansIncidenceRetrospective Studiesheart failurehospitalizationInfluenzarespiratory infection

Identifiers

PMID35837360
PMCPMC9231574
OpenAlexW4285162112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.